AzTrials
AzTrials

Tracheostomy ComplicationNCT05845775

Evaluation Of The Effect Of Morphological Structure On Dilatational Tracheostomy Interference Location And Complications

An observational study of Tracheostomy Complication, run by Melike Cengiz at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In recent years, percutaneous dilatational tracheostomy has become a frequently performed procedure in intensive care units. However, tracheostomy procedure has risks of complications of varying severity, such as bleeding, subcutaneous emphysema, posterior tracheal wall damage, tracheal stenosis, infection, and… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Tracheostomy Complication
What is being tested?
Percutaneous dilatational tracheostomy, Bronchoscopy and ultrasonography
How many people
104 participants
Where
1 siteTurkey (Türkiye)
Study dates
30 Apr 2023to 2 Feb 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients over the age of 18 who were decided to open percutaneous dilatational tracheostomy for various reasons will be included in the study.

Who may be able to join

  • ● Clinical indication for tracheostomy

Who cannot join

  • Age <18
  • Patients with severe coagulopathy
  • Unsuitable anatomy (e.g., previous cervical surgery, cervical trauma, or tumors)

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Akdeniz University School of Medicine, Department of Anesthesiology and Intensive Care, Turkey

    Antalya

Other trials in Turkey (Türkiye)

About this study

Official title: Evaluation Of The Effect Of Morphological Structure On Dilatational Tracheostomy Interference Location And Complications By Ultrasonography And Fiberoptic Bronchoscopy

In recent years, percutaneous dilatational tracheostomy has become a frequently performed procedure in intensive care units. However, tracheostomy procedure has risks of complications of varying severity, such as bleeding, subcutaneous emphysema, posterior tracheal wall damage, tracheal stenosis, infection, and fistula in the early and late periods. It is important to determine the anatomical position for tracheal puncture in reducing the risk of complications. It is not always possible to determine the optimal anatomical position for tracheal puncture in patients in the intensive care unit due to reasons such as obesity patient positioning difficulties and tracheal deviation. In this stuy, we have purpose to evaluate the effect of the morphological structure of patients on the dilatational tracheostomy interference location and complications in the percutaneous dilatational tracheostomy procedure (using anatomical landmarks) performed with the forceps dilatation technique, using fiberoptic bronchoscopy and ultrasonography.

Read the detailed description

A prospective observational study will be conducted in the Akdeniz University Hospital at the department of Anesthesiology and Intensive Care. Tracheostomy incision site will be determined by using anatomical landmark in all patients. Before the procedure, detailed anatomical measurements showing the morphological structure of the patient (neck thickness, thyromental distance, thyroid cartilage measurement, cricoid cartilage measurement, jugulomental distance, distance between clavicle and cricoid cartilage) will be recorded. In addition, measurements will be made and recorded by ultrasonography. In all patients, the percutaneous dilatational tracheostomy procedure will be performed via fiberoptic bronchoscopy and the tracheal puncture level will be confirmed. Tracheostomy related complications will also be recorded.

Being tested
Percutaneous dilatational tracheostomy, Bronchoscopy, ultrasonography, Bronchoscopy application, Ultrasound examination
Keywords
Complications, Intensive care unit, Tracheostomy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Percutaneous dilatational tracheostomyProcedure or surgery

    The percutaneous dilatational tracheostomy procedure will be performed via fiberoptic bronchoscopy

  • BronchoscopyDevice

    Fiberoptic bronchoscopy

  • ultrasonographyDevice

    ultrasonography

  • Bronchoscopy applicationDiagnostic test

    Fiberoptic bronchoscopy application

  • Ultrasound examinationDiagnostic test

    Ultrasound examination

Study groups in NCT05845775
Study groupRoleWhat they receive
percutaneous dilatational tracheostomyPatients assigned to percutaneous dilatational tracheostomy
Receives: Procedure: Percutaneous dilatational tracheostomy; Device: Bronchoscopy; Device: ultrasonography; Diagnostic Test: Bronchoscopy application; Diagnostic Test: Ultrasound examination

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The effect of morphological structure on the percutaneous dilatational tracheostomy

    The relationship of anatomical position for tracheal puncture and complications with morphological structure of the patient (neck thickness, thyromental distance, thyroid cartilage measurement, cricoid cartilage measurement, jugulomental distance, distance between clavicle and cricoid cartilage)

    Measured: April 30, 2023-October 30, 2023 (6 months)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 May 2023
  2. Study start30 Apr 2023
  3. Primary completion2 Feb 2024
  4. Study completion2 Feb 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
104 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05845775
Sponsor's protocol ID
Akdeniz University Medicine
Status last verified
Mar 2024
First submitted
15 Apr 2023
Last updated
19 Mar 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Tracheostomy Complication, run by Melike Cengiz at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The effect of morphological structure on the percutaneous dilatational tracheostomy (time frame: April 30, 2023-October 30, 2023 (6 months)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Mar 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in